Fieldfisher‘s team, renowned for its ’deep understanding of the life science landscape in the UK‘ handles work spanning key stage funding for novel transactional funding for pharmaceutical products, regulatory assistance in areas of new technologies and M&A work in the life sciences space. ’Very experienced operator’
Janita Good heads up the team and is equipped to assist clients with M&A exits and pharma IP partnering deals.
Sarah Ellson is frequently called upon to assist with appeals against commercial decisions made by NICE.
Vicky Reinhardt, dual qualified in Germany and England, is well placed to assist life sciences clients with the commercial exploitation of products.